Choose Your Cannabis Method

About Orforglipron: The GLP-1 Gastric Slowing Effect

Orforglipron (Foundayo) is itself an oral medication processed through the GI tract — the first oral small-molecule GLP-1 agonist. This creates a unique concern not present with injectable GLP-1s: oral cannabis products and Foundayo are both competing for GI processing simultaneously. Foundayo has specific administration requirements (empty stomach, only water for 30+ minutes before) that oral cannabis products directly conflict with.

MethodAffected by GLP-1?Onset on OrforglipronPrimary Risk
EdiblesYes — significantly delayed2–4+ hours⚠️ Caution
SmokingNo — lung absorption1–10 min (unchanged)🔵 Moderate
VapingNo — lung absorption1–10 min (unchanged)🔵 Moderate
TincturesPartial — depends on techniqueMixed (15 min–4+ hours)🔵 Moderate
CBD OilYes — oral absorption delayed2–4+ hours🔵 Moderate

Check Your Full Medication List

Taking Orforglipron plus other medications? Use InteractSafe to review your complete combination.

Orforglipron + Cannabis Full Profile →

Or open the full interaction checker · Free · No account required

Other GLP-1 Medications